Tech Company Financing Transactions
Portal Access Funding Round
Portal Access secured a $7 million Series A investment round on 5/27/2025. Investors included private investors.
Transaction Overview
Company Name
Announced On
5/27/2025
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors
Proceeds Purpose
The funds will support regulatory activities and the planned 510(k) submission for approval to the U.S. Food and Drug Administration (FDA) for Flexi-Port� SLF-TANL�, a novel subcutaneous port designed to simplify vascular access for oncology patients and a limited market launch.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Undisclosed
Miami, FL Undisclosed
USA
Miami, FL Undisclosed
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
PorTal Access, Inc is a medical device start-up company pioneering next-generation advanced vascular access solutions for oncology. Founded by Dr. Michael Tal, Interventional Radiologist and serial entrepreneur, PorTal Access, Inc. is committed to designing solutions that aim to reduce complications currently associated with chemo port placement, while offering a safe and minimally invasive option for bedside or in an outpatient setting with its revolutionary Flexi-Port� SLF-TANL� device.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Tal
Browse more venture capital transactions:
Prev: 5/27/2025: Infinity Constellation venture capital transaction
Next: 5/27/2025: Hedera Dx venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs